Midecamycin A3

• Description :

  Midecamycin A3 is a macrolide compound with strong anti-Gram-positive bacteria and weak anti-Gram-negative bacteria, mycobacteria and fungi activity[1].

• UNSPSC :

  12352005

• Target :

  Bacterial

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Infection

• Smiles :

  C[C@H](C/C=C/C=C\1)OC(C[C@@H](OC(CC)=O)[C@H](OC)[C@@H](O[C@H]2O[C@H](C)[C@@H](O[C@H]3O[C@@H](C)[C@H](OC(CC)=O)[C@@](O)(C)C3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)C1=O)=O

• Molecular Formula :

  C41H65NO15

• Molecular Weight :

  811.95

• References & Citations :

  [1]Y Matsuhashi, et al. The enzymatic interconversion between midecamycin A1 and A3. J Antibiot (Tokyo) . 1979 Jul;32 (7) :777-9.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Natural Products

• Clinical Information :

  No Development Reported

• CAS Number :

  [36025-69-1]